Dose Optimization Study of Idelalisib in Follicular Lymphoma

First published 08/09/2016

Last updated 23/05/2024

EU PAS number:

EUPAS15094

Study

Finalised

Documents

Study protocol

Initial protocol

amd-2-prot GS-US-313-1580-synopsis only

English (194.63 KB - PDF) View document

Updated protocol

GS-US-313-1580-appendix-16.1.1-protocol Amendment 6_f-redact

First published: 22/02/2024

English (3.37 MB - PDF) View document

Study results

GS-US-313-1580 - CSR Synopsis_f-redact

English (630.65 KB - PDF) View document

Study report

Other information

Secondary tabs